Glyburide/Metformin Hydrochloride

格列本脲/盐酸二甲双胍

Report date: 2023/04/25 13:50:54

Base Information

Drug NameGlyburide/Metformin Hydrochloride
Drug Alias Name格列本脲•盐酸二甲双胍Glibenclamide/Metformin HydrochlorideGlyburide and Metformin Hydrochloride格列本脲和盐酸二甲双胍格列本脲+二甲双胍 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsSulfonylurea receptor 1 inhibitors
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1Sulfonylurea receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryUnited States
Original Approved Date2000/07/31
Country/TerritoryUnited StatesMainland China
CombinationsYes Metformin HydrochlorideGlibenclamide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesShanxi Aolin Pharmaceutical Co Ltd
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD02
Related LinksKEGG